Please use this identifier to cite or link to this item: http://hdl.handle.net/11718/6908
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBalasubramaniam, K. V.
dc.contributor.authorSridharan, R.
dc.date.accessioned2010-08-04T04:37:33Z
dc.date.available2010-08-04T04:37:33Z
dc.date.copyright1991
dc.date.issued2010-08-04T04:37:33Z
dc.identifier.urihttp://hdl.handle.net/11718/6908
dc.description.abstractThe case illustrates a situation where the company had to decide on whether to discontinue production of its main product. The decision is influenced by government policy changes, international competition, and efficiency of the company's operations. The case has conceptual focus on elements of manufacturing strategy, especially in relation to international competitiveness, and uses elements of costs and its comparisons with international levels to identify strategic thrusts.en
dc.language.isoenen
dc.subjectPharmaceuticalsen
dc.subjectProduction Managementen
dc.titleBiotech Pharma Limiteden
dc.typeCases and Notesen
Appears in Collections:Cases and Notes

Files in This Item:
There are no files associated with this item.


Items in IIMA Institutional Repository are protected by copyright, with all rights reserved, unless otherwise indicated.